Explain this page
Arphra AIPlain-English read on CareDx, Inc’s valuation06-07today
- CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?1d
- CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress2d
- CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress2d
- CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overvalued4d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$8.78
-66.46% vs spot
Recommendation
Sell
7 of 8 methods
Method spread
1bull5bear
±5% threshold
Analyst PT consensus: $27.00 (+3.13%)
Candlestick · 1Y
Open in chart workstation →CDNA
26.18+28.21%H 26.26L 15.56MA50 19.77MA200 —Avg vol 684K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +11.50% | +13.73% | +23.78% | +52.65% | +34.60% | +38.96% | +37.50% | +217.72% | -71.48% | +408.35% | +189.28% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$279.73K
1 txn
Net flow
−$279.73K
Aftermarket
LiveLast trade
$26.16
15 sh
Bid
$25.71
35 sh
Ask
$26.19
1 sh
Spread
$0.480
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $117.7M | $2.81M | $0.05 |
| Q4 Dec 2025 | $108.39M | -$4.11M | $-0.08 |
| Q3 Sep 2025 | $100.06M | $1.68M | $0.03 |
| Q2 Jun 2025 | $86.68M | -$8.57M | $-0.16 |
| Q1 Mar 2025 | $84.69M | -$10.35M | $-0.19 |
| Q4 Dec 2024 | $86.58M | $78.01M | $1.51 |
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?zacks.com·Jun 19, 2026
- CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congressbusinesswire.com·Jun 18, 2026
- CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congressbusinesswire.com·Jun 18, 2026
- CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overvaluedgurufocus.com·Jun 16, 2026
- CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrologybusinesswire.com·Jun 16, 2026
- CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrologybusinesswire.com·Jun 16, 2026
- CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plansmarketbeat.com·Jun 08, 2026
- CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 08, 2026
Peers
No peer list available for CDNA.
Total assets
$413.23M
Total debt
$19.68M
Cash & equiv
$65.43M
Operating CF
$42.03M
Free cash flow
$36.12M
Buybacks
-$87.77M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Valantine Hannah director | Sell | 12,103 | $279.73K | Jun 15, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $379.81M | -$21.02M | -$21.35M | $-0.40 | -5.62% |
| FY 2024 | $333.79M | $40.77M | $52.55M | $0.93 | +15.74% |
| FY 2023 | $280.32M | -$203.36M | -$190.28M | $-3.54 | -67.88% |
| FY 2022 | $321.79M | -$77.23M | -$76.61M | $-1.44 | -23.81% |
| FY 2021 | $296.4M | -$29.73M | -$30.66M | $-0.59 | -10.34% |